Business Context and Reporting Period
Company: National Presto Industries, Inc.
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2004
National Presto Industries operates through three segments: Housewares/Small Appliances (pressure cookers, kitchen electrics), Defense Products (ordnance assemblies for the U.S. government), and Absorbent Products (private label diapers and incontinence products). The company has transitioned its housewares manufacturing entirely to outsourcing in the Orient, while expanding its defense and absorbent product capabilities through acquisitions and capital investment.
Key Financial Metrics
| Metric (in thousands) | 2004 | 2003 |
|---|---|---|
| Net Sales | $158,956 | $125,744 |
| Gross Profit | $40,066 | $37,461 |
| Gross Margin % | 25.2% | 29.8% |
| Operating Profit | $19,121 | $18,849 |
| Net Earnings | $15,441 | $15,477 |
| Earnings Per Share (Diluted) | $2.26 | $2.27 |
| Cash from Operating Activities | $4,806 | $24,797 |
| Cash and Cash Equivalents (Year End) | $104,724 | $143,765 |
| Working Capital | $208,772 | $220,132 |
| Current Ratio | 5.3 to 1.0 | 5.0 to 1.0 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net sales increased 26% to $158.96 million, driven primarily by the Defense segment (up 145%) and Absorbent Products segment (up 146%). The Housewares segment saw a modest 2% increase.
- Profitability: Net earnings remained flat, decreasing slightly by $36,000. This stability occurred despite a 26% revenue increase, largely due to a $3.53 million pension plan termination charge and reduced LIFO reserve benefits compared to 2003.
- Cash Flow: Operating cash flow dropped significantly to $4.8 million from $24.8 million, attributed to working capital changes (inventory build-up) and the pension charge. Investing cash outflow was $35.9 million, primarily for machinery and equipment to expand defense and absorbent product capacity.
- Segment Performance: Housewares gross margin declined from 32% to 29% due to pricing pressures and reduced LIFO benefits. Defense gross margin remained stable at 32%. Absorbent products margin decreased from 6.2% to 5.5% due to capacity constraints while fulfilling increased order volume.
Guidance, Outlook, and Risks
- Outlook: Management anticipates continued capital investment in the defense and absorbent segments. The defense segment has a backlog of approximately $43 million, expected to be fulfilled over 14 to 18 months.
- Customer Concentration: Significant reliance on major customers exists. Wal-Mart accounted for 30% of consolidated net sales in 2004. Medline Industries accounted for 11% of sales in the absorbent segment.
- Supply Chain Risks: The housewares segment relies entirely on outsourcing to the Orient. Risks include labor disputes, supply disruptions, and transportation delays which could impact availability during peak holiday seasons.
- Legal Proceedings: The SEC filed a lawsuit in 2002 alleging the company operated as an unregistered investment company. Management is vigorously defending the case; an unfavorable outcome could require asset reallocation or registration as an investment company.
- Environmental: The Eau Claire, Wisconsin site is on the EPA National Priorities List. Management believes current accruals are adequate for ongoing remediation, though future requirements could increase costs.
Investor Verification Checklist
- Customer Concentration: Verify the stability of the relationship with Wal-Mart (30% of sales) and Medline Industries (11% of sales).
- Supply Chain Resilience: Assess the risks associated with 100% outsourcing of housewares manufacturing to the Orient and potential disruption impacts.
- Capital Expenditure ROI: Monitor the utilization of the $22.5 million capital expenditure in the absorbent segment to ensure it generates expected returns given the recent margin compression.
- Legal Exposure: Track the status of the SEC lawsuit regarding unregistered investment company status.
- Backlog Execution: Confirm the Defense segment's ability to fulfill the $43 million backlog within the projected 14-18 month timeframe.